
Results 1 - 15 of 15 in Femara, Letrozole (generic)
Common Drug May Prevent Bone Loss from Breast Cancer Treatment
University of Pittsburgh Cancer Institute researchers found that some breast cancer patients may be able to prevent bone loss by adding zoledronic acid to their treatment plan. Comment?
Bisphosphonates and Beyond: Managing Bone Density and Reducing Breast Cancer
Bisphosphonates are routinely given to women with postmenopausal breast cancer, but new data suggests that these agents may play a role in reducing recurrent breast cancer as well. Comment?
Drug for cancer is easier to find
A HEALTHCARE assistant was spurred into action to improve the supply of cancer fighting drugs after a breast cancer patient was unable to get her prescription. Comment?
I thought I would take this time to pass along some basic and important information about breast cancer. Comment?
ASCO Expert Corner: Hormone Therapy Options for Early-Stage Breast Cancer
Hormone therapy is a treatment option for women with early-stage, hormone-sensitive breast cancer, identified by the presence of hormone receptors. Comment?
Newer Drug Beats Tamoxifen for Older Breast Cancer Patients
w/Photo
For postmenopausal women with breast cancer, treatment with the drug letrozole increases survival after surgery more than the widely used tamoxifen, a new study confirms. Comment?
Newer Drug Beats Tamoxifen for Older Breast Cancer Patients
w/Photo
For postmenopausal women with breast cancer, treatment with the drug letrozole increases survival after surgery more than the widely used tamoxifen, a new study confirms. Comment?
Newer Drug Beats Tamoxifen For Older Breast Cancer Patients
For postmenopausal women with breast cancer, treatment with the drug letrozole increases survival after surgery more than the widely used tamoxifen, a new study confirms. Comment?
Results In 'The New England Journal Of Medicine' Confirm Novartis...
Main Category: Breast Cancer Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 20 Aug 2009 - 2:00 PDT Newly published data in The New England Journal of Medicine affirm five-year upfront use of Femara ) following surgery as an optimal treatment approach versus tamoxifen for postmenopausal women with ... Comment?
Newer Drug Beats Tamoxifen for Older Breast Cancer Patients, Study
For postmenopausal women with endocrine-responsive early breast cancer, a sequence of the aromatase inhibitor letrozole (Femara) and tamoxifen holds no advantage over letrozole alone, although it may be better than tamoxifen alone. Comment?
Femara Increases Survival after Breast Cancer Surgery More Then Tamoxifen
For postmenopausal women with breast cancer, treatment with the drug letrozole increases survival after surgery more than the widely used tamoxifen, a new study confirms. Comment?
My name is Shanna Bailey. I am hoping that for those of you who find their ways here that you can use this group as a group of friends that you can ask questions and have someone to talk to, because I know how hard it can be to try to find someone to talk to when you are frustrated with TTC. Comment?
The combination of two drugs-- Femara and follicle-stimulating hormone --could be of benefit in infertile women of advanced reproductive age undergoing intrauterine insemination, results of a study indicate. Comment?
Fertility Drug Combo Promising In Older Women, Study
The combination of two drugs -- Femara (letrozole) and follicle-stimulating hormone (FSH) -- could be of benefit in infertile women of advanced reproductive age undergoing intrauterine insemination, results of a study indicate. Read at Reuters Comment?
Fertility drug combo promising in older women
The combination of two drugs -- Femara and follicle-stimulating hormone -- could be of benefit in infertile women of advanced reproductive age undergoing intrauterine insemination, results of a study indicate. Comment?